We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.01%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$13.4M
(-8.3%)
Cap. Flow
+$5.17M
Cap. Flow
% of AUM
3.49%
Top 10 Holdings %
Top 10 Hldgs %
33.04%
Holding
120
New
14
Increased
23
Reduced
48
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$3.37M |
| 2 |
UPH
UpHealth, Inc.
UPH
|
+$2.17M |
| 3 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$1.55M |
| 4 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.35M |
| 5 |
Journey Medical
DERM
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VG
Vonage Holdings Corporation
VG
|
+$2.56M |
| 2 |
ZIXI
Zix Corporation
ZIXI
|
+$1.63M |
| 3 |
Vericel Corp
VCEL
|
+$997K |
| 4 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
+$585K |
| 5 |
OptimizeRx
OPRX
|
+$557K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.42% |
| 2 | Technology | 16.73% |
| 3 | Industrials | 7.3% |
| 4 | Consumer Staples | 6.91% |
| 5 | Communication Services | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$132B
| $1.03M | 0.69% |
16,508
+58
| +0.4% | +$3.4K |
|
|
RYM
52
RYTHM Inc
RYM
$50.1M
| $1.02M | 0.69% |
37
+2
| +6% | +$97.3K |
|
53
Village Farms International
VFF
$239M
| $1.01M | 0.68% |
157,550
+137,550
| +688% | +$1.01M |
|
|
SRXH
54
SRX Global
SRXH
$28.5M
| $995K | 0.67% |
158
+9
| +6% | +$64.7K |
|
55
AT&T
T
$159B
| $943K | 0.64% |
50,758
-2,671
| -5% | -$49.9K |
|
56
Merck
MRK
$318B
| $922K | 0.62% |
12,025
-250
| -2% | -$19.9K |
|
57
Verizon
VZ
$192B
| $915K | 0.62% |
17,617
-108
| -0.6% | -$5.63K |
|
58
Apple
AAPL
$4.45T
| $879K | 0.59% |
4,950
| – | – |
|
59
MDxHealth
MDXH
$23.6M
| $857K | 0.58% |
+90,000
| New | +$882K |
|
60
BioLife Solutions
BLFS
$1.54B
| $783K | 0.53% |
21,000
| – | – |
|
|
61
Journey Medical
DERM
$181M
| $758K | 0.51% |
+140,800
| New | +$1.02M |
|
|
PRFT
62
DELISTED
Perficient Inc
PRFT
| $737K | 0.5% |
5,700
-1,400
| -20% | -$184K |
|
63
CryoPort
CYRX
$765M
| $680K | 0.46% |
11,500
| – | – |
|
64
ePlus
PLUS
$2.47B
| $647K | 0.44% |
12,000
| – | – |
|
65
International Flavors & Fragrances
IFF
$20.5B
| $646K | 0.44% |
4,285
-1,175
| -22% | -$171K |
|
66
Fastenal
FAST
$54.7B
| $615K | 0.42% |
19,200
| – | – |
|
67
Option Care Health
OPCH
$3.5B
| $603K | 0.41% |
21,200
-1,300
| -6% | -$34.1K |
|
|
QUMU
68
DELISTED
Qumu Corp.
QUMU
| $595K | 0.4% |
280,700
-58,700
| -17% | -$128K |
|
69
Donaldson
DCI
$11.1B
| $567K | 0.38% |
9,567
| – | – |
|
70
NXP Semiconductors
NXPI
$58.7B
| $558K | 0.38% |
2,450
| – | – |
|
71
CVS Health
CVS
$132B
| $553K | 0.37% |
5,359
| – | – |
|
72
AquaBounty Technologies
AQB
$4.74M
| $545K | 0.37% |
+12,975
| New | +$836K |
|
73
ANI Pharmaceuticals
ANIP
$1.82B
| $503K | 0.34% |
10,926
-3,150
| -22% | -$135K |
|
74
LifeVantage
LFVN
$83.3M
| $503K | 0.34% |
79,613
| – | – |
|
75
US Bancorp
USB
$99.1B
| $501K | 0.34% |
8,917
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Perkins Capital Management held 120 positions worth $148M, down 8.3% from $162M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Perkins Capital Management deployed $5.17M of net new capital in Q4 2021, opening 14 new positions and adding to 23 existing holdings. Its largest new stake was UpHealth, Inc.: 93,945 shares worth $2.1M.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 62% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Vericel Corp, an estimated $997K trimmed.
- Perkins Capital Management's largest Q4 2021 buy was UpHealth, Inc.: 93,945 shares worth $2.1M.
- Perkins Capital Management added most to ASPEN GROUP, INC. in Q4 2021, an estimated $3.37M increase.
- Perkins Capital Management's biggest Q4 2021 reduction was Vericel Corp, cutting an estimated $997K.
- Perkins Capital Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $2.56M.
- Perkins Capital Management's ten largest holdings make up 33% of its $148M portfolio in Q4 2021.
- Perkins Capital Management opened 14 new positions and closed 11 in Q4 2021.
- Perkins Capital Management's portfolio value fell 8.3% quarter-over-quarter to $148M.
Based on Perkins Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.